Published in Neurology on May 25, 2011
Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis. Neuropsychiatr Dis Treat (2011) 0.77
The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology (2011) 1.81
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93
Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects. Magn Reson Med (2004) 2.71
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2010) 2.44
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler (2011) 2.07
Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol (2008) 1.91
Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain (2004) 1.71
Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol (2012) 1.70
Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology (2010) 1.68
Will the real multiple sclerosis please stand up? Nat Rev Neurosci (2012) 1.61
Clinically isolated syndromes. Lancet Neurol (2012) 1.59
Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol (2010) 1.41
Resting state networks change in clinically isolated syndrome. Brain (2010) 1.41
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain (2008) 1.38
Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion (2010) 1.34
Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol (2007) 1.32
Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry (2012) 1.29
Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol (2009) 1.29
Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol (2009) 1.26
Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging (2006) 1.26
Brain atrophy and lesion load predict long term disability in multiple sclerosis. J Neurol Neurosurg Psychiatry (2013) 1.26
Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology (2006) 1.23
Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis. Eur Radiol (2008) 1.22
Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology (2013) 1.20
Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis (2005) 1.14
Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology (2009) 1.12
Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J Neuroinflammation (2012) 1.09
Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler (2011) 1.08
Localization of grey matter atrophy in early RRMS : A longitudinal study. J Neurol (2006) 1.06
Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology (2012) 1.05
Gray matter imaging in multiple sclerosis: what have we learned? BMC Neurol (2011) 1.03
Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. Radiology (2013) 1.03
Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain (2005) 1.02
In vivo MR imaging of hippocampal lesions in multiple sclerosis. J Magn Reson Imaging (2008) 1.02
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography. PLoS One (2012) 1.01
Structural and functional hippocampal changes in multiple sclerosis patients with intact memory function. Radiology (2010) 1.00
Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology (2008) 0.99
Functional connectivity changes in multiple sclerosis patients: a graph analytical study of MEG resting state data. Hum Brain Mapp (2011) 0.99
MS cortical lesions on DIR: not quite what they seem? PLoS One (2013) 0.99
Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size. J Magn Reson Imaging (2006) 0.98
Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR. Eur Radiol (2011) 0.96
Brain iron accumulation in aging and neurodegenerative disorders. Expert Rev Neurother (2012) 0.96
What explains gray matter atrophy in long-standing multiple sclerosis? Radiology (2014) 0.96
Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis. J Neuropathol Exp Neurol (2009) 0.95
Multiple sclerosis patients show a highly significant decrease in alpha band interhemispheric synchronization measured using MEG. Neuroimage (2005) 0.94
Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol (2009) 0.93
HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis. Arch Neurol (2009) 0.93
The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. J Neurol (2002) 0.93
Functional brain networks: linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG study. Hum Brain Mapp (2014) 0.93
Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies. CNS Neurol Disord Drug Targets (2011) 0.93
Grey matter damage in multiple sclerosis: a pathology perspective. Prion (2013) 0.93
Gender-related differences in functional connectivity in multiple sclerosis. Mult Scler (2011) 0.92
Cholinergic imbalance in the multiple sclerosis hippocampus. Acta Neuropathol (2011) 0.91
Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Neuroimage (2004) 0.90
The limits of functional reorganization in multiple sclerosis. Neurology (2010) 0.90
Longitudinal gray matter changes in multiple sclerosis--differential scanner and overall disease-related effects. Hum Brain Mapp (2011) 0.89
Application of a B-spline active surface technique to the measurement of cervical cord volume in multiple sclerosis from three-dimensional MR images. J Magn Reson Imaging (2003) 0.89
Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging. NMR Biomed (2014) 0.88
Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla. Eur Radiol (2013) 0.88
Subtraction MR images in a multiple sclerosis multicenter clinical trial setting. Radiology (2008) 0.88
Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis. Hum Brain Mapp (2011) 0.88
Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis. Hum Brain Mapp (2015) 0.87
Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration. J Magn Reson Imaging (2012) 0.87
Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter. Eur Radiol (2012) 0.86
Cortical imaging in multiple sclerosis: recent findings and 'grand challenges'. Curr Opin Neurol (2013) 0.86
Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications. Neurology (2012) 0.85
Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study. J Neurol (2015) 0.84
Histone deacetylase gene variants predict brain volume changes in multiple sclerosis. Neurobiol Aging (2012) 0.84
Multiple sclerosis as an "inside-out" disease. Ann Neurol (2010) 0.84
Milestone: neurology's growth factor: 100 years of Rita Levi-Montalcini. Nat Rev Neurol (2009) 0.84
Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: an exploratory study. J Magn Reson Imaging (2009) 0.83
Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials. Ann Neurol (2010) 0.83
Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline. Hum Brain Mapp (2013) 0.83
Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis. J Neuropathol Exp Neurol (2015) 0.82
Disruption of structural and functional networks in long-standing multiple sclerosis. Hum Brain Mapp (2014) 0.80
Diffusion MRI-based cortical complexity alterations associated with executive function in multiple sclerosis. J Magn Reson Imaging (2012) 0.80
B-cell depletion attenuates white and gray matter pathology in marmoset experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol (2011) 0.80
TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis. Mult Scler (2010) 0.79
Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective. Expert Rev Neurother (2007) 0.79
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis. Mult Scler (2012) 0.79
Steroid-responsive edema in CAA-related inflammation. J Neurol (2009) 0.78
Is progressive multiple sclerosis a gray matter disease? Ann Neurol (2008) 0.77
Imaging cortical damage and dysfunction in multiple sclerosis. JAMA Neurol (2013) 0.76
Ultra-high field MRI: looking through the 'macroscope'. J Neurol Neurosurg Psychiatry (2013) 0.76
Toward understanding cortical lesions in multiple sclerosis. Neurology (2010) 0.75
ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI. Mult Scler (2012) 0.75
The brake on neurodegeneration: Increased mitochondrial metabolism in the injured MS spinal cord. Neurology (2010) 0.75
What you see depends on how you look: Gray matter lesions in multiple sclerosis. Neurology (2009) 0.75
Neurodegeneration in MS and NMO: The Eye and the Blood. Mult Scler Int (2011) 0.75
Clinico-Pathological Correlations of the Frontal Lobe Syndrome: Results of a Large Brain Bank Study. Dement Geriatr Cogn Disord (2015) 0.75